SS
LAB icon

Sunbelt Securities’s Standard BioTools LAB Stock Holding History

Sunbelt Securities’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$155 Sell
169
-10
-6% -$12 ﹤0.01% 2563
2025
Q4 		$229 Hold
179
– – ﹤0.01% 2408
2025
Q3 		$233 Buy
+179
New +$234 ﹤0.01% 2389

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Sunbelt Securities's LAB Position: Q1 2026 in Review

Sunbelt Securities reduced its Standard BioTools (LAB) stake by 5.6% in Q1 2026, selling an estimated $12 and leaving 169 shares worth $155. The position accounts for ﹤0.01% of the portfolio, ranked #2563.

Sunbelt Securities first reported a position in LAB in Q3 2025 and has held it in 3 quarters since. The position peaked at $233 in Q3 2025. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Sunbelt Securities held 169 shares of Standard BioTools worth $155 as of Q1 2026.
  • Sunbelt Securities sold 10 Standard BioTools shares in Q1 2026, an estimated $12.
  • Standard BioTools made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2563 holding.
  • Sunbelt Securities first reported a position in Standard BioTools in Q3 2025 and has held it in 3 quarters since.
  • Sunbelt Securities's Standard BioTools position peaked at $233 in Q3 2025.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.